Large-scale testing (Phase 3)Study completedNCT00346073
What this trial is testing
Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years
Who this might be right for
Acellular PertussisDiphtheriaTetanus
GlaxoSmithKline 2,337